-resize-upscale(1).png?token=d8c96bd1d81472d08d67d51679b068e0)
-resize-upscale(1).jpeg?token=5e3ee5cfcb72bb83ea24cfb157dfffa2)
Bringing together investors, professionals, and executives
-resize-upscale(1).jpeg?token=ecd60916f10a3b5e92e51f81267b2e44)
Cantilever Business Partners is a true business partnership between our company, investors in our capital fund, startup business founders and visionaries, and a network of independent professionals. We assemble the best team for each startup, guiding their operation and strategic planning to ensure commercial success and exceptional returns.
Cantilever provides expertise, operational support, and executive management to carefully selected early-stage startups transitioning to the marketplace.
C- LEVEL SEASONED ENTREPRENEURS
Next to Funding, Talent, and support of the early-stage company founders is an essential part of early-stage company success. This often involves embedded fractional C-Level talent when and only when needed. Critical activities include daily oversight of startup activities, strategic acquisition of talent, and support of fundraising efforts necessary to bring the startup to commercialization. Cantilever’s talent consists of C- Level professionals with Ph.D. and MBA training, years of relevant industry experience, and real-world entrepreneurial successes.
“The biggest need of many of these tech startups is someone with relevant experience to be a part of the management team to bring the team forward” - Sandra Cochrane, Assistant Dean of WMed Innovation Center
FINANCIAL STRATEGY AND ACCESS TO FUNDING
Beyond simple balance sheets and financial projections, our staff help founders strategically plan their funding efforts and burn rates in order to maximize the use of all $$’s invested into the company. Additionally, Cantilever’s network connects entrepreneurs to the right funders at the right time.
“So many of these company founders don’t know how to turn their financials into an actual funding PLAN” - Jon Leinonen, MIR Michigan Technological University
ACCELERATION
Cantilever believes wholeheartedly in the Business Model Canvas and Lean methodologies as the most assured way to success. In the words of Steve Blank, “A startup is an organization formed to find a scalable, repeatable business model”. We guide startups to rigorously validate their product-market fit, and then quickly accelerate with establishing their first customer, and building out their Go To Market strategy.
We work in the universities as EIR/MIR’s, as well as incubators and accelerators, and organizations like MIHQ, a 40-acre innovation campus that houses over 50 early-stage companies.
We work with tech startups in many different fields, from manufacturing, life science, MedTech, materials, etc. We are tech-driven, but tech agnostic, as the creation of a business model stands on its own, independent on the technology being developed. We work best with tech startups that are just starting to show commercial promise.
Over the past 4 years, we have helped raise over 5.0 million in grants, spun out 6 university technologies, and raised $5.5 million for over 10 startups (all pre-revenue and pre-product)
In Collaboration with MI-HQ
.png?token=91d77d42a49e31ce61d3ec0d9ebc1fea)
Cantilever collaborates with MI-HQ (the Michigan Innovation Headquarters) to provide facilities and co-working spaces for startups and tech companies wishing to collaborate with local entrepreneurs.
Where do our clients find us?
.png?token=cf03fdd63eb9d82b68addb967f83d965)
.png?token=c60dcd9d72104667b3a356663ad2e53f)
.png?token=fe1d80ce5703c3e4975c2b42b9090317)
.png?token=ee93be9b78e4052ef21675307a39e60a)
.png?token=8c36b486cf6179afefcb5aaaacc7bfdf)
.png?token=b27ed20fa8174a46422c94845d910658)
.png?token=f371d000397c08bc9d2a9bbe3b5fe989)
.png?token=ba23dbbd90e8c24ac444b10350f29124)
.png?token=709699d33acc6f23107c56431573ff03)
.png?token=6a2133a4a090abc3d0a091890cecb41d)
-resize-upscale(1).png?token=ec0684ae3e584ef60cbce6492421058b)
-resize-upscale(1).png?token=ba1721ab609a264795e52a697f7b042e)
News
-resize-upscale(1).jpeg?token=6354722d1a8b1dcd2cb2f8e2f0340327)
Congratulations to Pathware
Congratulations to Pathware on their solid pitch efforts winning the Best Pitch Prize at TCnewtech.org! Pathware is providing the technology necessary for hospitals to perform successful biopsies on the first attempt. Continue Reading.
-resize-upscale(1).jpeg?token=dd42231b831043554483745e695b48f2)
WMU-born smart helmet technology earns Michigan small business honors for Portage company
Recently a ruling came out to limit the number of hits high school football players can get at practice," Tokarz said in the announcement on the award. "But what type of hits are we limiting? Continue Reading.
-resize-upscale(1).jpeg?token=6a971b886607719635ccee69d99fe82b)
Novolux Awarded "Up and Coming" Prize!
Gathering more than 500 attendees at the Detroit Masonic Temple, the 8th Annual Accelerate Michigan Innovation Competition awarded close to $1M in cash and in-kind services from WeWork, Varnum, Lambert & Edwards, Google, and Plante Moran. Continue Reading.
-resize-upscale(1).jpeg?token=41820f5547f2a0493d5aec66cf1cf483)
StabiLux Biosciences Receives $650,000 in Funding
StabiLux Biosciences (Novolux), a company founded by Michigan Technological University physics professor Yoke Khin Yap, has recently been awarded more than $650,000. Continue Reading.
-resize-upscale(1).jpeg?token=18540d3c345338d328e1f2155be73436)
New boost for high-brightness dyes research
StabiLux Biosciences, a spin-out company from research conducted at Michigan Technological University, has received an additional $500,000 supplementary grant from the National Science Foundation (NSF). Continue Reading.
-resize-upscale(1).jpeg?token=68ccef8e536cbdf80f5b1d10d200ef3f)
New Boost for High-brightness Dyes Research
StabiLux Biosciences, a spin-out company from research conducted at Michigan Technological University, has received an additional $500,000 supplementary grant from the National Science Foundation (NSF). This new NSF Small Business Technology Transfer (STTR) Phase IIB project, led by Nazmiye Yapici, Ph.D. ‘13, and Dongyan Zhang, adjunct associate professor in physics, will support the commercialization of high-brightness dyes for medical uses. Continue Reading.
-resize-upscale(1).jpeg?token=74190ab4ffea99e750bdd0b672395911)
Light Line Medical Recognized as ‘Most Valued Company’ at virtual Keiretsu Forum Investor Capital Expo
SEATTLE, WA—Light Line Medical, which has developed a proprietary method of delivering light to prevent and treat catheter-associated infections, was recognized as one of the top three ‘Most Valued Company’ at the Keiretsu Forum Investor Capital Expo that is showcasing 36 late-stage growth companies seeking funding. Nearly 50 angel groups, investors from 100+ Family Offices, corporate partners, and hundreds of accredited investors have attended the first two sessions of the Expo. Continue Reading.
-resize-upscale(1).png?token=a6e1172515b2e359f18413a739edc61b)
Acurx Announces All Patients Demonstrated Clinical and Sustained Cure in Ph2A Open-Label Trial of Ibezapolstat for Treatment of C. difficile Infection (CDI)
WHITE PLAINS, N.Y., Nov. 5, 2020 /PRNewswire/ -- Acurx Pharmaceuticals, LLC ("Acurx" or the "Company"), a privately held, clinical-stage biopharmaceutical company developing an entirely new class of antibiotics for difficult-to-treat bacterial infections, announced that all 10 patients (100%) with mild-to-moderate CDI enrolled in this Ph2A open-label clinical trial met the study's primary and secondary efficacy endpoints following treatment with orally administered ibezapolstat given 450 mg twice daily for 10 days. Continue Reading.